Company Overview

Update
Headquarters:
Ann Arbor, MI
Funding:
$47.7M
Categories:
Health Care
Description:
CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.

Detailed Description

Update

CytoPherx, Inc., founded in July 2007 and headquartered in Ann Arbor, Michigan, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.

The Company’s products are custom, patent-protected configurations of commercially available hollow fiber dialysis filters that are used in a proprietary manner to sequester and deactivate leukocytes in the patient’s blood system. The Company is initially focused on acute renal failure (ARF).

Current Team (1)

Update

Past Team (3)

Update

Board Members and Advisors (1)

Update

Investors (10)

Update

Offices/Locations (1)

Update
  • Office

    Ann Arbor, MI

    USA